Dr. Quin Wills

Quin Wills, Founder and CSO of Ochre Bio, develops RNA therapies for liver disease. An MD with PhDs in computational biology, mathematics and genomics, he founded Novo Nordisk’s Advanced Genomics Dept and has held roles at UCL and the Mayo Clinic.